237 related articles for article (PubMed ID: 33268723)
1. [Cachexia and Sarcopenia Associated with Lung Cancer].
Tanaka S; Takayama K
Gan To Kagaku Ryoho; 2020 Nov; 47(11):1537-1541. PubMed ID: 33268723
[TBL] [Abstract][Full Text] [Related]
2. A randomized phase II study of nutritional and exercise treatment for elderly patients with advanced non-small cell lung or pancreatic cancer: the NEXTAC-TWO study protocol.
Miura S; Naito T; Mitsunaga S; Omae K; Mori K; Inano T; Yamaguchi T; Tatematsu N; Okayama T; Morikawa A; Mouri T; Tanaka H; Kimura M; Imai H; Mizukami T; Imoto A; Kondoh C; Shiotsu S; Okuyama H; Ueno M; Takahashi T; Tsuji T; Aragane H; Inui A; Higashiguchi T; Takayama K
BMC Cancer; 2019 May; 19(1):528. PubMed ID: 31151425
[TBL] [Abstract][Full Text] [Related]
3. The regulatory approval of anamorelin for treatment of cachexia in patients with non-small cell lung cancer, gastric cancer, pancreatic cancer, and colorectal cancer in Japan: facts and numbers.
Wakabayashi H; Arai H; Inui A
J Cachexia Sarcopenia Muscle; 2021 Feb; 12(1):14-16. PubMed ID: 33382205
[TBL] [Abstract][Full Text] [Related]
4. Anamorelin hydrochloride for the treatment of cancer-anorexia-cachexia in NSCLC.
Zhang H; Garcia JM
Expert Opin Pharmacother; 2015 Jun; 16(8):1245-53. PubMed ID: 25945893
[TBL] [Abstract][Full Text] [Related]
5. Anamorelin for advanced non-small-cell lung cancer with cachexia: Systematic review and meta-analysis.
Nishie K; Yamamoto S; Nagata C; Koizumi T; Hanaoka M
Lung Cancer; 2017 Oct; 112():25-34. PubMed ID: 29191597
[TBL] [Abstract][Full Text] [Related]
6. ROMANA 3: a phase 3 safety extension study of anamorelin in advanced non-small-cell lung cancer (NSCLC) patients with cachexia.
Currow D; Temel JS; Abernethy A; Milanowski J; Friend J; Fearon KC
Ann Oncol; 2017 Aug; 28(8):1949-1956. PubMed ID: 28472437
[TBL] [Abstract][Full Text] [Related]
7. Association of sarcopenia and observed physical performance with attainment of multidisciplinary team planned treatment in non-small cell lung cancer: an observational study protocol.
Collins JT; Noble S; Chester J; Davies HE; Evans WD; Lester J; Parry D; Pettit RJ; Byrne A
BMC Cancer; 2015 Jul; 15():544. PubMed ID: 26204885
[TBL] [Abstract][Full Text] [Related]
8. Cancer cachexia, sarcopenia and biochemical markers in patients with advanced non-small cell lung cancer-chemotherapy toxicity and prognostic value.
Srdic D; Plestina S; Sverko-Peternac A; Nikolac N; Simundic AM; Samarzija M
Support Care Cancer; 2016 Nov; 24(11):4495-502. PubMed ID: 27236439
[TBL] [Abstract][Full Text] [Related]
9. Anamorelin (ONO-7643) for the treatment of patients with non-small cell lung cancer and cachexia: Results from a randomized, double-blind, placebo-controlled, multicenter study of Japanese patients (ONO-7643-04).
Katakami N; Uchino J; Yokoyama T; Naito T; Kondo M; Yamada K; Kitajima H; Yoshimori K; Sato K; Saito H; Aoe K; Tsuji T; Takiguchi Y; Takayama K; Komura N; Takiguchi T; Eguchi K
Cancer; 2018 Feb; 124(3):606-616. PubMed ID: 29205286
[TBL] [Abstract][Full Text] [Related]
10. Anamorelin (ONO-7643) in Japanese patients with non-small cell lung cancer and cachexia: results of a randomized phase 2 trial.
Takayama K; Katakami N; Yokoyama T; Atagi S; Yoshimori K; Kagamu H; Saito H; Takiguchi Y; Aoe K; Koyama A; Komura N; Eguchi K
Support Care Cancer; 2016 Aug; 24(8):3495-505. PubMed ID: 27005463
[TBL] [Abstract][Full Text] [Related]
11. Cancer cachexia in thoracic malignancy: a narrative review.
Kidd AC; Skrzypski M; Jamal-Hanjani M; Blyth KG
Curr Opin Support Palliat Care; 2019 Dec; 13(4):316-322. PubMed ID: 31592847
[TBL] [Abstract][Full Text] [Related]
12. Anamorelin in Japanese patients with cancer cachexia: an update.
Wakabayashi H; Arai H; Inui A
Curr Opin Support Palliat Care; 2023 Sep; 17(3):162-167. PubMed ID: 37389636
[TBL] [Abstract][Full Text] [Related]
13. Quality of life and survival survey of cancer cachexia in advanced non-small cell lung cancer patients-Japan nutrition and QOL survey in patients with advanced non-small cell lung cancer study.
Takayama K; Atagi S; Imamura F; Tanaka H; Minato K; Harada T; Katakami N; Yokoyama T; Yoshimori K; Takiguchi Y; Hataji O; Takeda Y; Aoe K; Kim YH; Yokota S; Tabeta H; Tomii K; Ohashi Y; Eguchi K; Watanabe K
Support Care Cancer; 2016 Aug; 24(8):3473-80. PubMed ID: 27003901
[TBL] [Abstract][Full Text] [Related]
14. Erlotinib plus parenteral nutrition: an opportunity to get through the hardest days of advanced non-small cell lung cancer with cancer anorexia-cachexia syndrome.
Zang YS; Fang Z; Li B
Am J Hosp Palliat Care; 2013 Mar; 30(2):210-3. PubMed ID: 23393267
[TBL] [Abstract][Full Text] [Related]
15. Impact of the Extent of Weight Loss before Administration on the Efficacy of Anamorelin in Advanced Pancreatic Cancer Patients with Cachexia.
Takeda T; Sasaki T; Okamoto T; Ishitsuka T; Yamada M; Nakagawa H; Mie T; Furukawa T; Kasuga A; Matsuyama M; Ozaka M; Sasahira N
Intern Med; 2023 Jul; 62(13):1887-1893. PubMed ID: 36418096
[TBL] [Abstract][Full Text] [Related]
16. [Pharmacological profile and clinical efficacy of anamorelin HCl (ADLUMIZ
Nakanishi Y; Higuchi J; Honda N; Komura N
Nihon Yakurigaku Zasshi; 2021; 156(6):370-381. PubMed ID: 34719572
[TBL] [Abstract][Full Text] [Related]
17. Feasibility of early multimodal interventions for elderly patients with advanced pancreatic and non-small-cell lung cancer.
Naito T; Mitsunaga S; Miura S; Tatematsu N; Inano T; Mouri T; Tsuji T; Higashiguchi T; Inui A; Okayama T; Yamaguchi T; Morikawa A; Mori N; Takahashi T; Strasser F; Omae K; Mori K; Takayama K
J Cachexia Sarcopenia Muscle; 2019 Feb; 10(1):73-83. PubMed ID: 30334618
[TBL] [Abstract][Full Text] [Related]
18. Optimising Outcomes in Non Small Cell Lung Cancer: Targeting Cancer Cachexia.
Phillips I; Stares M; Allan L; Sayers J; Skipworth R; Laird B
Front Biosci (Landmark Ed); 2022 Apr; 27(4):129. PubMed ID: 35468688
[TBL] [Abstract][Full Text] [Related]
19. A randomized phase II feasibility trial of a multimodal intervention for the management of cachexia in lung and pancreatic cancer.
Solheim TS; Laird BJA; Balstad TR; Stene GB; Bye A; Johns N; Pettersen CH; Fallon M; Fayers P; Fearon K; Kaasa S
J Cachexia Sarcopenia Muscle; 2017 Oct; 8(5):778-788. PubMed ID: 28614627
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of Anamorelin, a Novel Non-Peptide Ghrelin Analogue, in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) and Cachexia-Review and Expert Opinion.
Currow DC; Maddocks M; Cella D; Muscaritoli M
Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30400622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]